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Abstract
Amyloids are aggregated proteins characterized by a specific cross-b-sheet structure and are typically associated with
neurodegenerative diseases including Alzheimer’s disease. Recently, however, several nonpathological amyloids have been
found in intracellular organelles of normal mammalian tissues suggesting that amyloid may also carry out biological
functions. We previously have shown that the epididymal cystatin CRES (cystatin-related epididymal spermatogenic), cst8,a
reproductive-specific member of the cystatin superfamily of cysteine protease inhibitors, forms amyloid in vitro suggesting
that CRES amyloid may also form in vivo within the epididymal lumen. Here we show that amyloid structures containing
CRES are a component of the normal mouse epididymal lumen without any apparent cytotoxic effects on spermatozoa and
that these structures change along the length of the tubule. These studies suggest the presence of a functional amyloid
structure that may carry out roles in sperm maturation or maintenance of the luminal milieu and which itself may undergo
maturational changes along the epididymis. In contrast to previous examples of functional amyloid which were intracellular,
our studies now show that nonpathological/functional amyloid can also be extracellular. The presence of an extracellular
and nonpathological amyloid in the epididymis suggests that similar amyloid structures may be present in other organ
systems and may carry out distinctive tissue-specific functions.
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Introduction
Amyloids are aggregated proteins with a specific cross-b-sheet
structure that typically are associated with neurodegenerative
diseases such as Alzheimer’s and Parkinson’s disease. Several
nonpathological amyloids have recently been found in intracellular
organelles of normal mammalian tissues suggesting that amyloid
may also carry out biological functions. These include in
melanosomes the Pmel protein which forms an amyloid structure
involved in the synthesis of melanin [1] and the storage of several
hormones as amyloids in the pituitary gland [2]. The formation of
amyloid is a multi-step process in which proteins progress from
soluble oligomers to fibrils with the oligomeric amyloid thought to
be the cytotoxic species [3]. Because functional and pathological
amyloids are structurally similar, in normal tissues amyloidogen-
esis must be controlled to avoid cytotoxicity.
The epididymis is a highly convoluted tubule through which
spermatozoa must pass after exiting the testis in order to acquire
the functional capacities of progressive motility and the ability to
fertilize an oocyte. This maturation process requires the
interaction of spermatozoa with proteins synthesized and secreted
into the lumen in a region-dependent manner by the epididymal
epithelium [4]. In addition to maturation, the epididymal luminal
environment plays a critical role in the protection of the
spermatozoa since the viability of these cells must be maintained
in order for perpetuation of the species to occur. Because greater
than 90% of the water is absorbed from the fluid by the epithelium
as spermatozoa enter into the epididymis, the epididymal luminal
environment surrounding the spermatozoa is thought to be a
dense medium rich in particulate material of unknown function.
We have previously demonstrated that the reproductive cystatin
CRES (cystatin-related epididymal spermatogenic) (cst8), a mem-
ber of the cystatin superfamily of cysteine protease inhibitors, is
synthesized and secreted by the most proximal part of the mouse
epididymis (proximal caput, region 1) and thus may be involved in
the sperm maturation process [5]. We have also shown that the
monomeric 14 and N-glycosylated 19 kDa forms of CRES are
present within the lumen of the proximal caput but in more distal
epididymal regions disappear with a concomitant appearance of
CRES in high molecular mass structures [6]. Immunofluorescence
analyses also showed that in the distal epididymis CRES localized
to punctuate-type structures of unknown function [7]. In vitro
studies of the recombinant CRES protein demonstrated that it has
the capacity to readily form oligomeric and fibrillar amyloid-like
structures characteristic of those present in pathological conditions
such as Alzheimer’s disease [6]. In this regard CRES is similar to
the L68Q mutant form of human cystatin C which readily forms
amyloid and is the causative factor of hereditary cystatin C
amyloid angiopathy (HCCAA) in the Icelandic population [8].
Our observation that CRES forms amyloid in vitro raised the
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thus explain the transition of monomer to high molecular mass
structures. Therefore, the present studies were carried out to
determine if amyloid-like structures are present in the normal
mouse epididymal lumen and, in particular, whether CRES
contributes to the formation of these structures. Herein we show
that CRES amyloid is a component of the normal epididymal
luminal environment and thus the first example of a mammalian
extracellular nonpathological amyloid.
Materials and Methods
Animals/Ethics Statement
CD1 retired breeder male mice were purchased from Charles
River Laboratories (Wilmington, MA). Cst8 129SvEv/B6 gene
knockout and wildtype mice were bred in house. Mice were
maintained under a constant 12 h light/12 h dark cycle with food
and water ad libitum. All animal studies were conducted in
accordance with the NIH Guidelines for the Care and Use of
Experimental Animals using a protocol approved by the
TTUHSC IACUC.
Isolation of epididymal luminal fluid and pellet fractions
Epididymides were sectioned into five regions with 1, proximal
caput; 2, midcaput; 3, distal caput; 4, corpus; and 5, cauda or into
caput (regions 1–3) and corpus-cauda (regions 4–5). The tissue
sections were minced in PBS and luminal contents allowed to
disperse for 15 minutes. The suspension containing spermatozoa
and luminal proteins was centrifuged at 5006g for 5 min to pellet
spermatozoa (pellet 1) and any epithelial cells and the supernatant
removed and centrifuged again at 5006g to remove any
remaining cellular material. The supernatant representing the
total luminal fluid protein (soluble and particulate) was either used
directly in experiments or underwent differential centrifugation to
separate out particulate material of varying molecular mass. This
included centrifugation of the total luminal fluid first at 50006g
for 10 min (pellet 2), followed by centrifugation of the supernatant
at 15,0006g for 10 min (pellet 3) followed by centrifugation of the
supernatant in a Beckman ultracentrifuge at 250,0006g for 1 hour
(pellet 4). All pellets were resuspended in PBS and stored on ice. In
some experiments, pellet 4 was washed in PBS and extracted with
90% DMSO at room temperature for 1.5 hours prior to
centrifugation at 250,0006g for 1 hour. In other experiments,
after centrifugation to remove cellular material (pellet 1), the
supernatant was centrifuged at 250,0006g for 1 hour combining
pellets 2–4 into one high speed pellet. The final supernatant from
the last centrifugation was designated the supernatant fraction.
Dot blot and filter trap assays
For dot blot analysis, 10 mg of protein from the supernatant and
high speed pellet fractions from each of the five epididymal regions
was spotted on to nitrocellulose (Biotrace, Pall Corp, Ann Arbor,
MI) and incubated with either the A11 or OC antibodies
(Millipore, Billeria, MA) at 1:3000 or 1:5000, respectively in
TBST overnight at 4uC as described previously [6].
For filter trap assays, cellulose acetate membrane (Whatman
OE66, 0.2 mm) prewet in water was placed on top of PVDF
membrane (activated in methanol and then equilibrated in water)
which was placed on top of prewet filter paper in a dot blot
apparatus. PBS was added to each well and vacuum applied.
Samples (15 mg) were then loaded followed by a PBS wash. The
membranes were immediately placed in 3% milk/TBST (0.2%
Tween) to block for 1 hr at room temperature followed by
incubation with an affinity purified rabbit anti-mouse CRES
antibody 1 mg/ml at 4uC overnight. The specificity of the CRES
antibody for the CRES antigen has been previously established
[5]. The blots were washed 26in TBST, incubated with goat anti-
rabbit HRP-labeled secondary antibody (Thermo Scientific,
Rockford, IL) for 2 hrs at room temperature, washed in TBST
and incubated with chemiluminescence reagent (BioRad, Hercu-
les, CA).
Thioflavin S and Congo Red staining
Pellet samples were spread on to Superfrost Plus microscope
slides and allowed to air dry. Slides were incubated in 0.1%
Thioflavin S, prepared in water and filtered prior to use, for
2 hours at room temperature in the dark. The slides were washed
46 in water, 26 in 50% ethanol, followed by 26 in water and
mounted with VectaMount AQ (Vector Laboratories, Burlingame,
CA). For Congo Red, air dried slides were stained following the
method of Puchtler [9] overnight in a humidified chamber. Slides
were rinsed 56with water, 3695% ethanol, 46100% ethanol, 16
xylene and mounted with VectaMount (Vector Laboratories,
Burlingame, CA). For plate assays, samples were incubated with
20 mM thioflavin T and fluorescence determined with a Synergy
HT plate reader (BioTek, Winooski, VT) with excitation at
450 nm and emission at 485 nm.
Negative stain electron microscopy
Samples (5 ml) were either spotted on to formvar/carbon coated
200 mesh nickel grids (Ted Pella, Redding, CA) or the grid was
floated on the sample for 1 min. The sample was wicked off with
filter paper, washed for 1 min with water, stained with 2% uranyl
acetate for 1 min, and washed again with water for 1 min.
Samples were examined with a Hitachi 8100 electron microscope
operating at an excitation voltage of 75 kV.
CRES/Thioflavin S colocalization
Slides were stained with 0.05% Thioflavin S for 2 hours
following the protocol described above. After the last water wash,
slides were transferred to a humid plastic container and incubated
with 3.7% formaldehyde in PBS for 30 minutes at room
temperature. The fixative was wicked off and replaced with 1%
Triton X-100 for 3 minutes after which the slides were washed 36
in PBS containing 0.1% Tween (PBST) and then incubated with
an affinity purified rabbit anti-mouse CRES antibody 1 mg/ml in
PBST/10% goat serum at room temperature for 1 hour followed
by incubation at 4Cu overnight. The slides were washed with
PBST 56and incubated with a goat anti-rabbit Alexa Fluor 594
conjugated secondary antibody (Invitrogen, Grand Island, NY)
(1:250) in PBST/10% goat serum for 2 hours at room temper-
ature in the dark. Slides were washed 56in PBST, 16water and
mounted with VectaMount AQ. Slides were examined using a
Zeiss microscope equipped with epifluorescence with excitation at
425/40 nm and emission at 475 nm for Thioflavin S and 560/
40 nm excitation and 610 nm emission for Alexafluor 594.
Western blot analysis
Western blot analysis was carried out as described previously
using 15% Tris-glycine SDS-PAGE gels (Criterion, Bio-Rad,
Hercules, CA) [6].
Transmission electron microscopy
A high speed pellet from the caput epididymis was resuspended
in a small volume of Histogel and processed for Epon embedding
following standard protocols.
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Luminal fluid was centrifuged to remove spermatozoa and the
resulting supernatant was incubated with PAD ligand for 2 hours
at room temperature and washed following the manufacturer’s
protocol (Seprion, Microsens Biotechnologies, CalBioreagents,
San Mateo, CA), and eluted with 16Lammeli (2% SDS, 4% b-
mercaptoethanol) at 95uC for 5 minutes.
X-ray diffraction
Pellet 4 was isolated from the epididymis in 10 mM HEPES,
pH 7.4 with final resuspension in water. The solution was pulled
up into a 0.7 mm quartz capillary tube and allowed to air dry.
Samples were exposed to X-rays at 1.54 A ˚ for 15–30 minutes at
room temperature using a Rigaku Screen machine (Rigaku, The
Woodlands, TX).
Results
Amyloid in the epididymis
To determine whether amyloid structures are present in the
epididymal lumen a variety of approaches were used. First,
conformation-dependent antibodies, A11 and OC, which recog-
nize oligomeric and fibrillar forms of amyloid, respectively [10]
were used in dot blot analysis to characterize the forms of amyloid
in the epididymal fluid. Following removal of spermatozoa, a
supernatant and a high speed pellet fraction isolated from the
luminal fluid from each of the five regions of the mouse epididymis
were examined. These studies revealed the presence of amyloid-
like structures in both the supernatant and pellet fractions. Region-
dependent changes in the composition of the structures were also
observed with the caput (regions 1–3) containing oligomeric (A11)
and fibrillar (OC) forms of amyloid in both the supernatant and
pellet while the corpus-cauda (regions 4–5) contained amyloid only
in the pellet (Figure 1a). This suggests that a transition or
maturation of the amyloid structures may occur along the length
of the tubule with the cauda epididymis containing primarily
insoluble forms of amyloid.
To confirm the presence of amyloid, the conformation-
dependent dyes thioflavin S and Congo Red, which bind primarily
to fibrillar forms, were used to stain the structures in the high
speed pellet fractions which were then examined by fluorescence
microscopy. Both dyes bound to similar structures from the caput
and corpus-cauda epididymis, including a unique film-like
material, suggesting these structures were composed of cross- b-
sheets typical of amyloid (Figure 1b). Further fractionation by
sequential centrifugation and characterization of the pellet
fractions showed that in the caput epididymis a variety of large
aggregate structures that were thioflavin S positive were associated
with low centrifugation speeds (pellet 2, 50006g; pellet 3,
150006g) while the film-like material was associated with a
250,0006g pellet (pellet 4) (Figure 2a). In the cauda epididymis, a
mesh of small aggregate material was detected in pellet 2 (50006g)
while a beginning film-like material was detected in pellet 3
(150006g) and a dense film-like material was predominant in
pellet 4 (250,0006g). Although the cauda material was also
thioflavin S positive, supporting its possessing cross b-sheet
structure, the relative thioflavin S levels were profoundly reduced
compared to that in the caput epididymis (Figure 2a). This suggests
Figure 1. Amyloid structures in the mouse epididymal lumen. a) Dot blot analysis using All and OC antibodies to detect the oligomeric and
fibrillar amyloid structures, respectively, in supernatant and high speed pellet fractions isolated from the five regions of the mouse epididymis. b)
Thioflavin S (ThS) and Congo Red (CR) bound to similar structures including a film-like material (third panel) in the high speed pellet isolated from the
caput (regions 1–3) and corpus-cauda (regions 4–5) luminal fluid from the mouse epididymis. Bar, 5 mm. c) X-ray diffraction of a 250,0006g pellet
(pellet 4) isolated from the corpus-cauda luminal fluid. d) Transmission electron microscopy of an Epon embedded high speed pellet isolated from
the caput epididymal luminal fluid. Bar, 100 mm.
doi:10.1371/journal.pone.0036394.g001
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perhaps acquiring a different conformation in the cauda
epididymis that prevents thioflavin S staining. In support, the
thioflavin T fluorescence of pellet 4, as determined by plate assay,
showed an approximately 6-fold reduction in fluorescence in the
cauda epididymis compared to that in the caput (Figure 2b).
Because pellet 4 contained an enriched population of the film-like
amyloid rather than a heterogeneous mix of structures as observed
in the other pellets, we focused on characterizing this amyloid
structure in subsequent experiments.
To examine the crystallographic properties of the structures in
pellet 4, X-ray diffraction was performed on samples isolated from
the corpus-cauda epididymis. A major reflection at 4.7 A ˚,
representing spacing between strands in a b-sheet, and a more
diffuse reflection at approximately10 A ˚, representing spacing
between b-sheets, were observed (Figure 1c). Both reflections are
characteristic of cross-b-sheet structure present in amyloid [11].
Finally, the high speed pellet from the caput epididymis was
examined by standard transmission electron microscopy after
embedding in Epon to preserve structural integrity. Fibrils
approximately 10 nm in diameter typical of amyloid fibrils were
detected (Figure 1d).
Additional experiments were next carried out to determine
whether the thioflavin S positive film-like material was a normal
component of the luminal fluid and not created as a result of the
isolation procedure. The thioflavin S positive film-like material
was present in whole luminal fluid that underwent only a single
low speed centrifugation spin (5006g) to remove spermatozoa
demonstrating that this structure was not formed as a result of
ultracentrifugation (Figure 3a). To rule out that the film-like
material was due to contamination that occurred during the
mincing of the tissue, both caput and corpus-cauda epididymal
tubules were punctured to allow dispersion of the contents which
were then examined by thioflavin S staining. The thioflavin S
positive film-like material was again observed suggesting that it is a
normal component of the luminal fluid (Figure 3b).
Negative stain electron microscopy was next carried out to
characterize the amyloid structures in pellet 4 from the caput and
Figure 2. Regional changes in thioflavin staining in the epididymis. a) Sequential centrifugation was carried out to isolate particulate
material of varying molecular mass from the caput and corpus-cauda luminal fluid after first removal of spermatozoa by centrifugation at 5006g
(pellet 1). Pellet 2, 50006g; pellet 3, 150006g; pellet 4, 250,0006g. Samples were air dried on a slide and stained with 0.1% thioflavin S. All images
were captured with the same exposure times. Bar, 5 mm. b) 15 mg of protein from the caput (regions 1–3) and corpus-cauda (regions 4–5) pellet 4 was
examined for thioflavin T fluorescence in a plate assay. Mean6SEM of three experiments.
doi:10.1371/journal.pone.0036394.g002
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in both epididymal regions, the caput contained more ribbon-like
and branched polygon structures (Figure 4a,c) in addition to
fibrillar structures (Figure 4b) that were present within the ribbons,
while the corpus-cauda contained arrays of fibrils and filaments
(Figure 4g–i). Several of these structures appeared to have
amorphous material associated with them possibly representative
of protein-protein interactions between amyloid and nonamyloid
forming proteins (Figure 4c). Large prion-like structures that were
composed of stacked fibrils (Figure 4d, e) or a meshwork (Figure 4f)
were also observed in both regions. Taken together, these studies
show that amyloid structures are present within the normal mouse
epididymal lumen. Furthermore, there are region-dependent
changes along the epididymis in the composition of the amyloid
structures which may reflect either different amyloids or an
amyloid that is undergoing a transition to a different structure.
CRES amyloid in the epididymis
Studies were first carried out to examine the distribution of
CRES within the supernatant and pellet fractions isolated from the
luminal fluid. Although a proportion of CRES remained in the
supernatant (S) from caput region 1, CRES was also detected in
pellets 2–4 implying its presence in particulate structures
(Figure 5a). DMSO has been used in studies of amyloid forming
proteins as a means to disrupt aggregated b-sheets [12].
Pretreatment of pellet 4 with DMSO prior to Western blot
analysis resulted in the appearance of additional monomeric forms
of CRES suggesting that a proportion of the protein in this fraction
is in a higher order structure that is resistant to SDS but which is
reversed by DMSO (Figure 5a). Filter trap assays supported the
Western blot experiments since in the high speed pellet fractions
from all five epididymal regions CRES was detected on the
cellulose acetate membrane suggestive of its presence in a high
molecular mass structure that is trapped and unable to pass
through the membrane while CRES in the supernatant readily
passed through the filter to bind to the underlying PVDF
membrane (Figure 5b). The population of CRES in the
supernatant likely represents CRES monomers as well as soluble
oligomers, precursors to the later stage amyloid protofibrils and
fibrils [3].
To determine whether CRES amyloid was present in the
epididymis, colocalization studies were carried out. Immunofluo-
rescence analysis using an affinity-purified CRES antibody showed
that CRES colocalized with the thioflavin S positive film-like
material in pellet 4 from the caput epididymis suggesting CRES is
in an amyloid structure (Figure 5c). However, we were unable to
detect CRES in the film-like material in pellet 4 isolated from the
cauda epididymis (data not shown). We next incubated luminal
fluid samples with a polymeric ligand (protein aggregation disease
(PAD)) reagent consisting of repeating charged and hydrophobic
groups that interact with similar repeating groups on aggregated
proteins, and which has previously been shown to selectively
capture prion proteins [13] and oligomeric and fibrillar amyloid
from a Huntington’s disease mouse model [14]. As shown in
Figure 5d, the PAD ligand captured a proportion of CRES from
both the caput and corpus-cauda luminal fluid suggesting its
presence in the epididymal lumen as an amyloid structure. Similar
results were obtained when PAD ligand was used to capture
CRES from the luminal fluid from a CRES WT but not from a
CRES KO mouse model (Figure 5d). The 129 SvEv mouse strain
expresses higher levels of CRES than the CD-1 mice used in all
the other experiments and thus more CRES protein was captured
from the CRES WT by the PAD ligand in these studies.
Discussion
Amyloid in the epididymis
Taken together, our studies suggest that within the epididymis
CRES amyloid is a part of the normal extracellular environment
with no obvious detriment to the maturing spermatozoa and thus
may be an example of an amyloid that carries out biological roles
within the epididymal lumen. Specifically, using techniques that
are common to the amyloid field, including the use of
conformation-dependent antibodies and dyes, X-ray diffraction,
and electron microscopy we showed the presence of amyloid in the
epididymal lumen. Furthermore, colocalization studies using an
affinity purified CRES antibody and thioflavin S staining and
PAD ligand pulldown assays showed that CRES contributes to the
formation of amyloid within the epididymal lumen. The
epididymal amyloid may provide a critical infrastructure for the
transport of luminal proteins to the sperm surface as part of the
maturation process, serve as an organizational center for protein
interactions within the lumen, and/or as a means of extracellular
quality control.
Maturational changes in amyloid
Changes in amyloid were also detected along the epididymal
tubule which could reflect a maturational progression of the
amyloid into different structures or distinct region-specific
populations of amyloid. Indeed, region-dependent changes in
proteins are a hallmark of the epididymis and contribute to the
formation of region-dependent luminal microenvironments that
are essential for sperm maturation [15,16]. The caput epididymis
is the most metabolically active region and secretes the bulk of the
proteins found in the lumen. Many of these proteins remain in the
lumen and are found in the cauda epididymis while other proteins
are selectively removed or modified during epididymal transit.
Therefore, the apparent maturational change in the amyloid
structures from the caput to the cauda is consistent with
Figure 3. Thioflavin S staining of epididymal luminal fluid. a)
Caput luminal fluid was centrifuged to pellet spermatozoa and the
resulting supernatant dried on a slide and stained with thioflavin S.
Representative structures are shown. b) Luminal fluid was isolated after
puncturing the caput and corpus-cauda epididymal tubules with a
needle and allowing contents to disperse. After centrifugation to
remove spermatozoa, the supernatant was dried on a slide and stained
with thioflavin S. Bar, 5 mm.
doi:10.1371/journal.pone.0036394.g003
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events.
Specifically, while both the caput and cauda epididymis
contained a film-like amyloid material in the 250,0006g pellet
4, the intensity of the thioflavin S and thioflavin T fluorescence
was much lower in pellet 4, as well as in all pellets, from the cauda
epididymis compared to that in the caput suggesting that there was
less amyloid in the cauda compared to the caput epididymis.
However, studies of amyloidogenic proteins have shown that a
lack of thioflavin fluorescence can also be associated with an
amyloid that has acquired a higher ordered structure that is not
favorable for thioflavin binding [17–19]. To address this, studies
are currently ongoing to determine if the film-like material in pellet
4 as well as material in other pellets from the cauda epididymis can
be reversed to structures that show increased thioflavin binding.
In parallel with the maturational change in amyloid along the
epididymis, our ability to detect CRES amyloid also changed from
the caput to the cauda epididymis. Strong CRES immunofluores-
cence colocalized with strong thioflavin S fluorescence in the caput
pellet fractions while our inability to detect CRES in the cauda
pellets coincided with decreased thioflavin S fluorescence.
However, filter trap assays clearly suggest that CRES is present
in the cauda pellet fractions and PAD pulldown experiments
showed the presence of CRES amyloid in the cauda lumen. Thus
it may be that the mechanisms that result in reduced thioflavin S
binding contribute to our decreased ability to detect CRES in the
cauda epididymis. An alternate possibility to the formation of
higher ordered structures contributing to reduced thioflavin S
binding may be that in the cauda epididymis other modifications
such as transglutaminase crosslinking may have altered the
amyloid structures making them less able to bind thioflavin [6],
that the proteins contributing to the amyloid structures in the
cauda may be distinct from those in the caput and thus thioflavin
binding properties are different, or that amyloid structures are
actually being reversed within the cauda lumen, perhaps as a
prelude to removal from the lumen.
Control of amyloidogenesis in the epididymis
Previous examples of nonpathological/functional amyloid have
been found sequestered within cellular organelles thus providing
the cell some protection from cytotoxicity that can arise during
amyloidogenesis [20]. Indeed, although it was previously thought
Figure 4. Negative stain electron microscopic analysis of amyloid structures from the caput and corpus-cauda luminal fluid. The
250,0006g pellet 4 prepared from the caput (a–e) and corpus-cauda epididymal luminal fluid (f–i) was spotted on a grid, stained with 2% uranyl
acetate, and examined using a Hitatchi 8100 electron microscope. Panel e shows a higher magnification of panel d.
doi:10.1371/journal.pone.0036394.g004
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that it is the oligomeric forms of amyloid, precursors to fibrils, that
are cytotoxic by virtue of their ability to form pores/channels in
cell membranes and disrupt cell homeostasis [3,21]. The control of
Pmel amyloid formation is thought to occur at multiple levels in
addition to sequestration within the melanosome, including the
requirement for proteolytic processing by proprotein convertases
[22] and rapid kinetics of amyloid fibril formation avoiding
cytotoxic oligomeric intermediates [1]. Similarly, pituitary hor-
mones form amyloid in the secretory granules and this process is
thought to be controlled by proteolytic processing as well as
possible interactions with helper proteins [2]. Our studies showing
the presence of amyloid in the epididymal extracellular environ-
ment suggests that unique mechanisms must be in place to control
and/or protect against cytotoxicity during amyloidogenesis. This is
especially important within the epididymis since amyloid is present
in the same cellular compartment as spermatozoa and damage to
these cells must be avoided. It is possible that interactions with
chaperones may help to control cytotoxicity. Cystatin C is also
present within the mouse epididymal lumen and has been shown
to form amyloid in vitro [23]. Another possibility is that
interactions between several cystatin proteins form the amyloid
structures present within the lumen and this coordinated and
regulated interaction may be a mechanism to control amyloid
formation and avoid cytotoxicity. This would be similar to that
which occurs in bacteria where the interaction of several secreted
curli protein family members mediates the formation of a
functional amyloid structure [24].
Our studies show that nonpathological/functional amyloids can
be extracellular as well as intracellular which is similar to amyloids
associated with disease. These studies add to the growing list of
nonpathological/functional amyloids that have been detected
within mammals supporting the idea that these structures may
indeed be carrying out diverse biological functions in many organ
systems including the reproductive tract. Further studies of
epididymal amyloid including mechanisms that control its
formation will provide valuable insight towards understanding
uncontrolled amyloid formation as occurs in many neurodegen-
erative diseases.
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